Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Ablation Combined With PD-1 Antibody in Patients With Hepatocellular Carcinoma

NCT04652440 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT04652440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Ablation Combined With PD-1 Antibody in Patients With Hepatocellular Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 15, 2020
Completion date
June 30, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma